| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440539 | European Journal of Cancer | 2018 | 7 Pages |
Abstract
Mammography and US were underused in Neo-ALTTOÂ although US had the potential to assess early response whereas mammography to detect residual disease prior to surgery. Our data still emphasise the need for further imaging studies on pts treated with neoadjuvant HER2-targeted therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Di Cosimo, C. Campbell, H.A. Jr., G. Galli, G. Bregni, G. Curigliano, C. Criscitiello, M. Izquierdo, L. de la Pena, D. Fumagalli, L. Fein, J. Vinholes, W.M.J. Ng, M. Colleoni, A. Ferro, B.J. Naume, A. Patel, J. Huober, E. de Azambuja,